Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs STLD✓SelectedUSD · STLDMRNA vs STLD performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs STLD

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+149.2%
STLD return
+108.1%
Excess return
+41.2%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioSTLDExcessAlpha
1D-4.8%-0.9%-4.0%-4.8%
7D-20.9%-6.8%-14.0%-20.7%
30D-13.3%-9.2%-4.1%-13.1%
3M+212.6%-10.6%+223.2%+212.6%
6M+309.0%-2.1%+311.2%+290.9%
YTD+567.3%+32.4%+534.9%+458.3%
1Y+689.7%+45.6%+644.1%+535.4%
All+149.2%+108.1%+41.2%+72.3%

Cumulative growth

Daily Returns

Daily percentage return beside STLD.

Daily Out/Under-Performance

Portfolio return minus STLD return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × STLD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded STLD wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling